Sfoglia per RIVISTA
MINERVA UROLOGY AND NEPHROLOGY
Collezione AO Cuneo

  

Items : 5

Is EMA warning on quinolones and fluoroquinolones really assessed? An EudraVigilance database analysis. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Jun;75(3):374-380. doi: 10.23736/S2724-6051.23.05169-8. Epub 2023 Mar 20.

2023
AO Cuneo

DE Nunzio C; Nacchia A; Lombardo R; Franco A; Cicione A; Trucchi A; Labella M; Bartoletti R; Simonato A; Ficarra V; Tubaro A;

Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the North-West of Italy from 2007 to 2015. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Jun;75(3):388-397. doi: 10.23736/S2724-6051.22.04699-7. Epub 2022 Mar 11.

2023
ASL Città di Torino
ASL Vercelli
ASL Asti
ASL Torino 4
ASL VCO
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
ASL Alessandria
AOU Alessandria
ASL Novara

Roccatello D; Biancone L; Cusinato S; Besso L; Manganaro M; Mariano F; Vitale C; Chiarinotti D; Boero R; Cesano G; Filiberti O; Costantini L; Borzumati M; Vio P; Chiappero F; Todini V; Marciello A; Savoldi S; Deagostini C; Serra A; Martina G; Salomone M; Formica M; Stramignoni E; Gherzi M; Calabrese G; Roscini E; Maffei S; Marino A; et alii...

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

2023
AO Cuneo
ASL Cuneo 2
AOU Novara

Grande E; Santoni M; Buti S; Battelli N; Sorgentoni G; Pierantoni F; Monteiro FS; Rebuzzi SE; Roviello G; Soares A; Zabalza IO; Rizzo A; Bisonni R; Morelli F; Incorvaia L; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Messina C; Merler S; Landmesser J; Grillone F; Ortega C; Sunela K; Ansari J; Atzori F; Bassanelli M; et alii...

Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Feb;74(1):11-20. doi: 10.23736/S2724-6051.20.04032-1. Epub 2021 Jan 13.

2022
AO Cuneo
AOU Città della Salute di Torino

Conti GN; Valdagni R; Maggi S; Triggiani L; Tubaro A; Russi E; Noale M; Porreca A; Montironi R; Muto G; Mirone V; Maruzzo M; Magrini SM; Ingrosso G; Gacci M; Corvò R; Cicchetti A; Bracarda S; Borghetti P; Bertoni F; Bassi P; Artibani W; Antonelli A; Palumbo C; Bruni A;

The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Feb;74(1):38-48. doi: 10.23736/S2724-6051.20.03925-9. Epub 2020 Nov 17.

2022
AO Cuneo

Salonia A; Russi E; Ricardi U; Porreca A; Pecoraro S; Noale M; Muto G; Montironi R; Mirone V; Magrini SM; Maggi S; Graziotti P; Fusco F; DE Nunzio C; Corvò R; Conti GN; Carmignani L; Carmignani G; Briganti A; Bracarda S; Bertoni F; Bassi P; Artibani W; Greco I; Gacci M; Simonato A; Serni S; Tubaro A; Zagonel V; et alii...